Teva Pharmaceutical Industries Limited

    Jurisdiction
    Israel
    LEI
    549300BAFGM4RC74ZJ94
    ISIN
    US8816242098 (TEVA)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    InsiderPie Expert Score
    62 / 100
    Even with peer group:
    62 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. Read full profile

    Fundamentals

    Net revenue
    €14.18B
    Gross margin
    49.6%
    EBIT
    €762.54M
    EBIT margin
    5.4%
    Net income
    -€134.77M
    Net margin
    -1.0%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €14.48B +2.1% €2.71B -2,112.8%
    €14.88B +2.7% €3.04B +12.0%
    €15.03B +1.0% N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.09
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Hughes Eric A See "Remarks" -53K $15.16 -$799.57K
    Jover Placid See "Remarks" -6.1K $15.16 -$91.76K

    Investor transactions

    Name Shares Value Last change Change type
    Stanley Druckenmiller 15M $228.70M +5.9M Buy
    Andreas Halvorsen 10M $155.63M +3.6M Buy
    Peter Brown 5.3M $81.48M -1.7M Sell

    Earnings Calls

    Add to watchlist

    Notifications